We also used SIRT4‐specific short interfering RNAs (siRNAs) to deplete SIRT4 levels in the two breast cancer cell lines, and observed that the IC50 increased after SIRT4 depletion (Figure 1A,D). This evidence concerns the gene SIRT4 and breast carcinoma.